Business Description
Shenzhen Glory Medical Co Ltd
NAICS : 339113
SIC : 5047
ISIN : CNE1000010G6
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.82 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | -2.31 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.82 | |||||
Beneish M-Score | -2.68 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -20.7 | |||||
3-Year Book Growth Rate | -6 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.81 | |||||
9-Day RSI | 42.15 | |||||
14-Day RSI | 41.96 | |||||
6-1 Month Momentum % | -19.8 | |||||
12-1 Month Momentum % | -21.18 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.2 | |||||
Quick Ratio | 1.75 | |||||
Cash Ratio | 0.99 | |||||
Days Inventory | 146.38 | |||||
Days Sales Outstanding | 155.11 | |||||
Days Payable | 127.17 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1 | |||||
Shareholder Yield % | 2.85 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 16.57 | |||||
Operating Margin % | -1.67 | |||||
Net Margin % | -12.48 | |||||
FCF Margin % | 1.48 | |||||
ROE % | -5.44 | |||||
ROA % | -3.59 | |||||
ROIC % | -0.94 | |||||
ROC (Joel Greenblatt) % | -16.65 | |||||
ROCE % | -3.82 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 30.41 | |||||
PS Ratio | 2.04 | |||||
PB Ratio | 0.88 | |||||
Price-to-Tangible-Book | 0.99 | |||||
Price-to-Free-Cash-Flow | 390 | |||||
Price-to-Operating-Cash-Flow | 390 | |||||
EV-to-EBIT | -14.09 | |||||
EV-to-EBITDA | -14.09 | |||||
EV-to-Revenue | 1.48 | |||||
EV-to-FCF | 100.39 | |||||
Price-to-Projected-FCF | 1.67 | |||||
Price-to-Median-PS-Value | 0.66 | |||||
Price-to-Net-Current-Asset-Value | 4.57 | |||||
Earnings Yield (Greenblatt) % | -7.1 | |||||
FCF Yield % | 0.76 | |||||
Forward Rate of Return (Yacktman) % | -20.44 |